Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial

By Lin Chia-Chi   Hsu Chiun   Hsu Chih-Hung   Hsu Wei-Ling   Cheng Ann-Lii   Yang Chih-Hsin  

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 77-84

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of nolatrexed dihydrochloride [Thymitaq^TM, AG 337] in patients with advanced hepatocellular carcinoma

By Jhawer Minaxi   Rosen Lee   Dancey Janet   Hochster Howard   Hamburg Solomon   Tempero Margaret   Clendeninn Neil   Mani Sridhar  

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 85-94

Springer Publishing Company

Access to resources Recommend Favorite

Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 1, 2015-05 ,pp. : 54-60

Bentham Science Publishers

Access to resources Recommend Favorite

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 112-118

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma

By  

Journal of Digestive Diseases, Vol. 16, Iss. 9, 2015-09 ,pp. : 505-512

John Wiley & Sons Inc

Access to resources Recommend Favorite